PhosPrint is a laser bioprinter developer focusing on the highly precise and rapid delivery of cells and other bio-inks on the substrates of interest for tissue regeneration and biosensor applications.
Innovative in vivo laser bioprinting system
designed for regenerative medicine application in urology cutting-edge technology offering a novel alternative method to current treatment options for bladder cancer patients
Meet PhosDB I
A high-resolution, user-friendly laser bioprinter
for demanding cell-printing applications
Networking & Ecosystems
Latest news
events | press releases | media coverage
May 9, 2025
We are excited to share that our company was selected to participate in the HIAS Entrepreneurship Workshop 2025, hosted by the Hellenic Institute of Advanced Studies. This prestigious event brought together some of the most promising and innovative startups in Greece.
Our Co-Founder and CEO, Ioanna Zergioti, had the honor of presenting our latest technologies and solutions to a distinguished audience, alongside an inspiring group of fellow startup founders. The workshop fostered dynamic discussions, collaboration, and a shared vision for the future of innovation and entrepreneurship in Greece.
April 7, 2025
CEO Dr. Ioanna Zergioti Participates in ACCI Panel on the Future of Biotech & MedTech
CEO Dr. Ioanna Zergioti participated as a panelist in a high-level discussion organized by the Athens Chamber of Commerce and Industry (ΕΒΕΑ - ACCI), under the presidency of Ms. Sophia Efraimoglou-Kounenaki, and moderated by Dr. Eleni Episkopou.
The discussion focused on Europe’s role in shaping the global future of biotechnology and medical technology — from artificial intelligence to bioprinting — with ethics and equity at the center of innovation.
The panel also highlighted Greece’s unique potential to contribute actively and responsibly to the transformation of the healthcare sector through research, investment, and international collaboration.
February 26, 2025
On February 26th our CEO Dr Ioanna Zergioti participated in the “Female Startup Founders: Funding Innovative Investments” event, co-organized by ICC Women Hellas Finance cluster headed by Giota Stathakou and Startups cluster headed by Maria Hala.
The event hosted other dynamic Greek female founders and investors and was also attended by Ministers Niki Kerameus, Minister of Labour and Social Insurance, and Zoe Rapti Deputy Minister of Development.
Female investors panelists were Antigoni Lymperopoulou (CEO, Hellenic Development Bank of Investments), Evi Andrianou (Founding Managing Partner, Investment Committee Member, SouthBridge Advisors AIFM), Roula Bachtalia (Head of Venture Banking, Eurobank), Katerina Pramatari (Partner, Uni.Fund) and Georgia Stamatelou (Tax Partner, EY)
Female founders panelists in addition to our CEO Dr Ioanna Zergioti were Ekaterini Chatzaki (CEO & Founder ABCureD PC), Sofia Pomakidou (CEO & Founder @ΕVO Human Performance), Katerina Santikou (Founder Workathlon-exit), Machi Simeonidou (Managing Director AgroApps PC) and Elisavet Nika (Co-founder & Managing Director COVARIANCE P.C.)
December 25, 2024
PhosPrint welcomes 2025 with optimism, closing a successful year filled with achievements and milestones. The company completed its pre-clinical trials, received a new award, and showcased its innovative technology at key events. A highlight of the year was the special interview of CEO Ioanna Zergioti on Naftemporiki TV with Takis Spiliopoulos, marking the end of a pivotal chapter for the company.
Η PhosPrint υποδέχεται το 2025 με αισιοδοξία, κλείνοντας μια επιτυχημένη χρονιά γεμάτη διακρίσεις και προκλήσεις. Μεταξύ άλλων, η εταιρεία ολοκλήρωσε επιτυχώς τις προκλινικές δοκιμές, απέσπασε νέο βραβείο και παρουσίασε την καινοτόμο τεχνολογία της σε σημαντικά forums. Σημαντική στιγμή ήταν η συνέντευξη της CEO, Ιωάννας Ζεργιώτη, στην εκπομπή του Τάκη Σπηλιόπουλου στο Naftemporiki TV, σηματοδοτώντας το τέλος μιας καθοριστικής χρονιάς.
December 14, 2024
Our company was honored as one of the three finalists in the MedTech category at the prestigious Tech Gala Awards 2024, hosted by the European Innovation Council and SMEs Executive Agency (EISMEA) in collaboration with WLOUNGE. Representing us at this exceptional gathering were our CEO, Ioanna Zergioti, and Biologist Eleni Damianidou. We extend our heartfelt thanks to EISMEA, WLOUNGE, and the entire Tech Gala Awards team for organizing this remarkable event.
Η εταιρεία μας είχε την τιμή να αναδειχθεί ως μία από τις τρεις φιναλίστ στην κατηγορία MedTech στα κορυφαία Tech Gala Awards 2024, που διοργανώθηκαν από το European Innovation Council και την SMEs Executive Agency (EISMEA), σε συνεργασία με το WLOUNGE. Στην ξεχωριστή αυτή εκδήλωση μας εκπροσώπησαν η CEO μας, Ιωάννα Ζεργιώτη, και η Βιολόγος Ελένη Δαμιανίδου. Εκφράζουμε τις θερμές μας ευχαριστίες στο EISMEA, το WLOUNGE και την οργανωτική ομάδα των Tech Gala Awards για τη διοργάνωση αυτής της μοναδικής εκδήλωσης.
PhosPrint Among the Finalists at WLOUNGE Tech Awards Gala 2024
We are thrilled and very proud to be included in the Tech Awards Gala 2024 #WTA2024 in Berlin, as one of the 3 Top Finalists in the MedTech category. The award ceremony will take place on December 14, 2024, at the iconic Rotes Rathaus in Berlin.
Είμαστε ενθουσιασμένοι και περήφανοι για την επιλογή της PhosPrint στις 3 καλύτερες εταιρείες MedTech στα περίφημα WLOUNGE Tech Awards Gala 2024. που θα πραγματοποιηθεί στο εμβληματικό Rotes Rathaus στο Βερολίνο στις 14 Δεκεμβρίου.
PhosPrint at HTIS 2023 (9–11 December, Bruges)
PhosPrint will be participating in the HealthTech Investor Summit (HTIS) in Bruges, Belgium, from 9th to 11th December. We will showcase our innovative in vivo laser bioprinting system, designed for regenerative medicine application in urology. This cutting-edge technology offers a novel alternative method to the current treatment options for bladder cancer patients.
Η PhosPrint στο HTIS 2023 (9–11 Δεκεμβρίου, Μπριζ)
Η PhosPrint θα συμμετάσχει στο HealthTech Investor Summit (HTIS), που θα πραγματοποιηθεί στην Μπριζ του Βελγίου, από τις 9 έως τις 11 Δεκεμβρίου. Θα παρουσιάσουμε το καινοτόμο μας σύστημα in vivo laser βιοεκτύπωσης, μία εφαρμογή αναγεννητικής ιατρικής στην ουρολογία. Αυτή η τεχνολογία αιχμής προσφέρει μια νέα εναλλακτική μέθοδο στις τρέχουσες θεραπευτικές επιλογές για ασθενείς με καρκίνο της ουροδόχου κύστης.
Contact
PhosPrint
Lefkippos Technology Park, NCSR Demokritos
Patriarchou Grigoriou 5’ & Neapoleos 27
153 41, Agia Paraskevh, Athens, Greece
Tax Registration Number: 801099345
General Electronic Commercial Registry (GEMI)
Nr: 149072501000
